Cargando…
Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells
BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anticancer drugs but their effect on tumor treatment has been disappointing mainly due to the acquisition of HDAC inhibitor resistance. However, the mechanisms underlying such resistance remain unclear. METHODS: In this study, we perfor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528251/ https://www.ncbi.nlm.nih.gov/pubmed/32998768 http://dx.doi.org/10.1186/s40659-020-00294-3 |